Search results for "hypertrophy"

showing 10 items of 335 documents

Impact of metabolic syndrome on left ventricular mass: Is the same in all ethnic groups and in men and women?

2007

[1] Mule G, Nardi E, Cottone S, et al. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects. Int J Cardiol 2007;121:267–75. [2] Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8. [3] IsomaaB,Almgren P, TuomiT, et al. Cardiovascularmorbidity andmortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9. [4] Reilly MP, Rader DJ. The metabolic syndrome:…

Malemedicine.medical_specialtyRaceEthnic groupSindrome metabolica Ipertrofia ventricolare sinistra Ipertensione essenziale.OverweightLeft ventricular hypertrophyEssential hypertensionLeft ventricular massLeft ventricular massRace (biology)Sex FactorsDiabetes mellitusInternal medicineHumansMedicineCardiac structureObesityInternational diabetes federationbusiness.industryRacial GroupsGenderOverweightmedicine.diseaseMetabolic syndromeHypertensionCardiologyFemaleHypertrophy Left Ventricularmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC‐HTA study

2007

The aim of this study is to assess the relationship among metabolic syndrome (MS), target organ damage (TOD) and established cardiovascular disease (CVD) in non-diabetic hypertensive elderly patients. ERIC-HTA is cross-sectional, multicentre study carried out in primary care, on hypertensive patients aged 55 or older. MS was defined by the NCEP-ATP III criteria, using body mass index (28.8 kg/m(2)) instead of abdominal perimeter. In 8331 non-diabetic hypertensive patients (3663 men and 4668 women, mean age 67.7 years), the prevalence of MS was 32.6% (men: 29.0%; women: 36.8%). A linear association was observed between a greater number of components of MS and a greater prevalence of left ven…

Malemedicine.medical_specialtyRenal functionDiseasePrimary careInternal medicinePrevalenceInternal MedicinemedicineHumansAgedMetabolic SyndromeLeft ventricle hypertrophybusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseTarget organ damageOrgan damageCross-Sectional StudiesCardiovascular DiseasesSpainHypertensionCardiologyFemaleHypertrophy Left VentricularMetabolic syndromeCardiology and Cardiovascular MedicinebusinessBody mass indexBlood Pressure
researchProduct

Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk

2015

OBJECTIVE This study was designed to evaluate the relationship among circulating adiponectin (ADPN), left ventricular mass (LVM) and cardiometabolic comorbidities in subjects at higher global cardiovascular risk (score of “ Cuore Project “) METHODS. 115 consecutive subjects were grouped according to normal or low ADPN levels. Left ventricular internal diameter (LVID/h), total LV mass (LVM), LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters, by pulsed-wave Doppler were calculated. RESULTS Low-ADPN subjects were characterized by a significant higher prevalence of some cardiometabolic comorbidities (obesity, visceral obesity, dia…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaCardiac VolumeHeart VentriclesCardiac VolumeLeft ventricular hypertrophyRisk AssessmentVentricular Function LeftLeft ventricular massRisk FactorsInternal medicinePrevalencemedicineHumansEchocardiography Doppler PulsedVentricular functionAdiponectinbusiness.industryStroke VolumeAdiponectinGlobal cardiovascular riskleft ventricular hypertrophyGeneral MedicineStroke volumeMiddle AgedPrognosismedicine.diseaseItalyCardiovascular DiseasesCardiologyFemaleAdiponectinCardiology and Cardiovascular MedicinebusinessBiomarkersActa Cardiologica
researchProduct

Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy

2014

This study was designed to evaluate the prevalence of cardiometabolic comorbidities and the changes in left ventricular geometry and function in 135 subjects subgrouped according to low or normal total adiponectin plasma (ADPN) levels. Left ventricular (LV) internal diameter/height, total LV mass (LVM) and LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters by pulsed-wave Doppler were calculated. Body mass index (BMI) (p < 0.0001), waist-to-hip ratio (p < 0.03), triglycerides (p < 0,001), prevalence of obesity (p < 0.005), visceral obesity (p < 0.003), left ventricular hypertrophy (LVH) (p < 0.001), metabolic syndrome (p < 0.000…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaDiastoleBlood PressureComorbidityLeft ventricular hypertrophyBody Mass IndexCoronary artery diseaseMetabolic DiseasesInternal medicineInternal MedicinemedicineHumansObesityAgedAged 80 and overEjection fractionAdiponectinbusiness.industrymedicine.diseaseAdiponectin Cardiometabolic comorbidities Left ventricular hypertrophyBlood pressureCardiovascular DiseasesEmergency MedicineCardiologyFemaleHypertrophy Left VentricularAdiponectinMetabolic syndromebusinessBody mass indexMetabolism Inborn Errors
researchProduct

Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities.

2019

BACKGROUND: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients. MATERIALS AND METHODS: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) b…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesHemodynamics030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineWaist–hip ratioobesity cardiac structureInternal medicinemedicineHumansCardiac structure030212 general & internal medicineObesityPhenomicsskin and connective tissue diseasesCorrelation of DataEchocardiography Doppler PulsedAdiponectinbusiness.industryCardiometabolic Risk FactorsStroke VolumeGeneral MedicineOrgan SizeMiddle Agedmedicine.diseaseObesityBlood pressureItalyEchocardiographycardiovascular systemCardiologyFemaleHypertrophy Left Ventricularsense organsAdiponectinCardiology and Cardiovascular MedicinebusinessFunction (biology)Acta cardiologica
researchProduct

Cardiac arrhythmias as correlated with the circadian rhythm of arterial pressure in hypertensive subjects with and without left ventricular hypertrop…

1990

To evaluate the relationship among supraventricular and ventricular arrhythmias with blood pressure and heart rate (HR) values, we studied 2 groups of 20 hypertensive men with (group I) and without (group II) left ventricular hypertrophy. Ambulatory electrocardiographic tracings were recorded continuously, together with ambulatory arterial pressure. Systolic (SBP) and diastolic (DBP) blood pressure values measured over 24 h showed no difference between the two groups, but we found greater variability in SBP in group I. The incidence of ventricular and supraventricular arrhythmias was significantly higher in patients of group I; moreover, we found a strong correlation between the incidence o…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaSystoleHeart VentriclesDiastoleBlood PressureCardiomegalyLeft ventricular hypertrophyVentricular Function LeftMuscle hypertrophyHeart RateInternal medicineHeart ratemedicineHumansPharmacology (medical)cardiovascular diseasesSystolePharmacologySupraventricular arrhythmiamedicine.diagnostic_testbusiness.industryArrhythmias CardiacGeneral Medicinemedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheCircadian RhythmBlood pressureHypertensioncardiovascular systemCardiologybusinessArrhythmias Cardiac/physiopathology* Blood Pressure/physiology* Cardiomegaly/physiopathology* Circadian Rhythm/physiology* Heart Rate/physiology Heart Ventricles/physiopathology Humans Hypertension/complications Male Systole Ventricular Function Left/physiologyElectrocardiographycirculatory and respiratory physiology
researchProduct

Inappropriately high left ventricular mass: Marker of very high cardiovascular risk in patients with chronic kidney disease

2012

There is increasing knowledge of the burden of cardiovascular (CV) diseases affecting patients with chronic kidney disease (CKD). CV diseases are the main cause of death in the CKD population, and the majority of patients with CKD die before ever reaching the end-stage renal disease; in fact, for patients with CKD, the risk of a fatal CV event is much higher than the risk to develop end-stage renal disease. Although patients with CKD manifest a high prevalence of traditional CV risk factors, this does not fully account for the burden of CV diseases in CKD.

Malemedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryPhysiologymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareLeft ventricular massEndocrinologyCardiovascular DiseasesInternal medicineCardiovascular DiseasemedicineCardiologyInternal MedicineHumansKidney Failure ChronicIn patientFemaleHypertrophy Left VentricularbusinessCardiology and Cardiovascular MedicineUltrasonographyKidney diseaseHuman
researchProduct

Physical training and connective tissues in young mice-heart

1976

The effect of physical training on the chemical properties of the heart tissues was studied in male mice of NMRI-strain. The mice to be trained and their controls were about 2 weeks old at the beginning of the training, which took place on 5 degrees inclined treadmill 5 days a week for 3-22 weeks. The duration of daily exercise was progressively increased over the first 3 weeks. The final daily exercise bouts were 50 and 80 min for moderate programs and 180 min for the intensive program at a speed of 30 cm/s. The whole heart or the ventricles were used for the analyses. We found no significant changes related to training in the concentrations of nitrogen, hexosamines, and hydroxyproline bot…

Malemedicine.medical_specialtySports medicineNitrogenPhysiologyMale miceCardiomegalyMicePhysical Conditioning AnimalPhysiology (medical)medicineAnimalsOrthopedics and Sports MedicineTreadmillbusiness.industryMyocardiumPublic Health Environmental and Occupational HealthHexosaminesGeneral MedicineHuman physiologySurgeryHydroxyprolineConnective TissueCardiac hypertrophyAnesthesiaHeart tissuesbusinessEuropean Journal of Applied Physiology and Occupational Physiology
researchProduct

Long-Term Follow-Up of Children with Surgically Treated Vesicorenal Reflux: Renal Growth

1991

Renal growth after successful surgical correction of vesicoureterorenal reflux (VUR) in childhood was observed in 137 female and 22 male patients over a mean follow-up period of 10.5 years. The renal parenchymal area was determined using a compensatory planimeter. For each measured value, the standard deviation score (SDS) was calculated by comparison with a normal population. On average, renal growth after reflux operation nearly paralleled the expected normal growth rate. Scarred kidneys had a worse growth prognosis than refluxing renal units (RU) without renal damage, growth retardation being correlated with the degree of pyelonephritic changes. The diminished growth rate of scarred kidn…

Malemedicine.medical_specialtyTime FactorsAdolescentLong term follow upUrologyCompensatory growth (organ)UrologyKidneyurologic and male genital diseasesVesicoureteral refluxMuscle hypertrophyCicatrixReference ValuesHumansMedicineChildVesico-Ureteral RefluxKidneybusiness.industryRefluxHypertrophymedicine.diseaseSurgeryAccelerated Growthmedicine.anatomical_structureFemaleRenal growthbusinessFollow-Up StudiesEuropean Urology
researchProduct

Selected enzyme activities in mouse cardiac muscle during training and terminated training

1984

We studied the effects of running-training, heavy exercise and termination of training on the heart weight, the ratio heart to body weight and the cardiac muscle activities of actomyosin ATPase, citrate synthase, succinate dehydrogenase, cytochrome c oxidase, malate dehydrogenase, adenylate kinase and beta-glucuronidase with adult male NMRI-mice. Stable hypertrophy (6-7%), estimated by the ratio heart or ventricle weight to body weight, was achieved by 28 exercises and it was dependent on the running speed (20 vs. 25 m X min-1). The withdrawal of training for 5-61 days did not permanently decrease the heart weight or the heart to body weight ratio to the level of sedentary controls. The act…

Malemedicine.medical_specialtyTime FactorsHeart diseasePhysiologyATPasePhysical ExertionCardiomegalyMice Inbred StrainsCitrate (si)-SynthaseBiologyMalate dehydrogenaseMitochondria HeartMuscle hypertrophyMicePhysiology (medical)Internal medicinemedicineAnimalsCitrate synthaseGlucuronidaseAdenosine TriphosphatasesCardiac muscleActomyosinmedicine.diseaseMyocardial ContractionMitochondria MuscleEndocrinologymedicine.anatomical_structureVentriclebiology.proteinHeart enlargementCardiology and Cardiovascular MedicineOxidation-ReductionBasic Research in Cardiology
researchProduct